top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

11.85 +0.02 (+0.17%)
Streaming Delayed Price Updated: 3:11 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®
From Medifast
Via Business Wire
News headline image
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
From Medifast
Via Business Wire
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Medifast ↗
 
Via Benzinga
News headline image
3 Reasons to Avoid MED and 1 Stock to Buy Instead
Over the past six months, Medifast’s stock price fell to $11.62. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 11.3%. This might have... 
Via StockStory
Topics Stocks
News headline image
Medifast Announces Planned Leadership Transition
From Medifast
Via Business Wire
News headline image
1 Consumer Stock to Target This Week and 2 We Question
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted... 
Via StockStory
Topics Stocks
News headline image
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers. 
Via StockStory
Topics Economy
News headline image
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
From Medifast
Via Business Wire
News headline image
3 Stocks Under $50 We’re Skeptical Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
From Medifast
Via Business Wire
News headline image
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call
Medifast’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively as sales continued to decline sharply year-over-year. Management attributed these results to... 
Via StockStory
Topics Earnings
News headline image
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges
Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of... 
Via StockStory
News headline image
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates
Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of... 
Via StockStory
Topics Artificial Intelligence
News headline image
Medifast Announces Third Quarter 2025 Financial Results
From Medifast
Via Business Wire
News headline image
Medifast Earnings: What To Look For From MED
Wellness company Medifast (NYSE:MED) will be announcing earnings results this Monday after market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
2 Cash-Heavy Stocks Worth Your Attention and 1 We Avoid
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
From Medifast
Via Business Wire
News headline image
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
From Medifast
Via Business Wire
News headline image
2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
3 Stocks Under $50 We Steer Clear Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
3 Reasons MED is Risky and 1 Stock to Buy Instead
Medifast has been treading water for the past six months, recording a small loss of 0.7% while holding steady at $13.57. The stock also fell short of the S&P 500’s 18.4% gain during that period. 
Via StockStory
Topics Stocks
News headline image
3 Reasons to Avoid MED and 1 Stock to Buy Instead
Medifast currently trades at $13.57 per share and has shown little upside over the past six months, posting a small loss of 0.7%. The stock also fell short of the S&P 500’s 18.4% gain during that... 
Via StockStory
Topics Stocks
News headline image
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
From Medifast
Via Business Wire
News headline image
3 Cash-Heavy Stocks We Find Risky
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
Why Medifast (MED) Stock Is Trading Up Today
Shares of wellness company Medifast (NYSE:MED) jumped 4.5% in the afternoon session after the broader market rallied as Federal Reserve Chair Jerome Powell indicated a willingness to consider interest... 
Via StockStory
Topics Economy Stocks
News headline image
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers. 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page